Enliven Therapeutics (ELVN) Earnings Date & Reports
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ELVN is expected to report earnings to rise 2.18% to -50 cents per share on November 06
Q3'25
Est.
$-0.50
Q2'25
Beat
by $0.06
Q1'25
Missed
by $0.07
Q4'24
Beat
by $0.06
Q3'24
Beat
by $0.03
The last earnings report on August 13 showed earnings per share of -49 cents, beating the estimate of -55 cents. With 467.56K shares outstanding, the current market capitalization sits at 1.22B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ELVN showed earnings on August 13, 2025. You can read more about the earnings report here.